Veracyte Ownership | Who Owns Veracyte?

Overview Forecast RevenueFinancials Chart Transcripts

Veracyte Ownership Summary

Veracyte is owned by 100.12% institutional investors, 0.83% insiders. Vanguard group is the largest institutional shareholder, holding 10.66% of VCYT shares. Vanguard Explorer Inv is the top mutual fund, with 3.49% of its assets in Veracyte shares.

VCYT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Veracyte	100.12%	0.83%	-0.95%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	8.21M	10.66%	$325.18M
Blackrock	7.79M	10.42%	$168.88M
Blackrock funding, inc. /de	7.53M	9.77%	$298.00M
Artisan partners limited partnership	6.60M	8.57%	$261.33M
Ark investment management	4.20M	5.46%	$166.48M
Wellington management group llp	4.08M	5.30%	$161.75M
Arrowmark colorado	3.08M	4.00%	$121.97M
State street	2.91M	3.89%	$63.03M
Dimensional fund advisors lp	2.88M	3.74%	$114.16M
Nikko asset management americas	2.49M	3.24%	$98.66M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Silverarc capital management	503.28K	4.36%	$19.93M
Perkins capital management	90.20K	3.17%	$3.57M
Next century growth investors	577.68K	1.71%	$22.88M
Arrowmark colorado	3.08M	1.64%	$121.97M
Oberweis asset management inc/	748.72K	1.40%	$29.65M
Ark investment management	4.20M	1.39%	$166.48M
Peregrine asset advisers	90.59K	1.32%	$3.59M
Virtus investment advisers	40.69K	1.26%	$1.61M
Efg asset management (north america)	206.23K	1.11%	$8.16M
Granite investment partners	649.02K	1.11%	$25.70M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	2.08M	0.00%	2.02M
Artisan partners limited partnership	6.60M	0.39%	1.58M
Marshall wace, llp	956.58K	0.05%	846.49K
Blackrock	7.79M	0.00%	581.69K
Point72 asset management	523.16K	0.05%	523.16K

Top Sellers

Holder	Shares	% Assets	Change
Champlain investment partners	800.36K	0.20%	-1.73M
State street	2.91M	0.00%	-1.42M
William blair investment management	-	-	-811.79K
Ark investment management	4.20M	1.39%	-716.79K
Fiera capital	-	-	-625.54K

New Positions

Holder	Shares	% Assets	Change	Value
Loomis sayles & co l p	409.70K	0.02%	409.70K	$16.22M
Norges bank	225.60K	0.00%	225.60K	$8.93M
Raymond james financial	41.06K	0.00%	41.06K	$1.63M
Tudor investment corp et al	38.88K	0.00%	38.88K	$842.62K
Proficio capital partners	29.78K	0.00%	29.78K	$29.78K

Sold Out

Holder	Change
Opal wealth advisors	-13.00
First command advisory services	-20.00
Covestor	-22.00
Park place capital	-24.00
Baldwin brothers llc/ma	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	301	2.73%	77,106,580	-5.52%	100	0.89%	145	-9.94%	109	22.47%
Sep 30, 2024	292	22.18%	81,612,672	-0.60%	105	0.88%	162	38.46%	88	7.32%
Jun 30, 2024	239	-2.05%	82,106,462	0.48%	109	0.92%	117	-21.48%	82	24.24%
Mar 31, 2024	244	-3.17%	81,711,223	5.83%	109	0.98%	149	29.57%	66	-37.14%
Dec 31, 2023	252	6.33%	77,206,775	1.07%	105	0.96%	115	-8.73%	105	36.36%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Explorer Inv	2.70M	3.49%	-98.92K
ARK Disruptive Innovation Full Composite	2.68M	3.46%	-285.96K
Vanguard US Total Market Shares ETF	2.46M	3.16%	2.69K
ARK Innovation ETF	2.45M	3.14%	-23.46K
Vanguard Total Stock Mkt Idx Inv	2.43M	3.12%	1.79K
iShares Russell 2000 ETF	2.05M	2.63%	-17.77K
Vanguard Small Cap Index	1.98M	2.54%	1.62K
Nikko AM ARK Disruptive Innovation A USD	1.69M	2.17%	-64.10K
Fidelity Select Medical Tech and Devcs	1.44M	1.85%	299.44K
SPDR® S&P Biotech ETF	1.36M	1.74%	-14.58K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 07, 2025	Leite John	Chief Commercial Officer-CLIA	Sell	$160.15K
Mar 07, 2025	Leite John	Chief Commercial Officer-CLIA	Sell	$74.48K
Mar 04, 2025	Febbo Phillip G.	Chief Scientific & Med Officer	Sell	$121.21K
Mar 04, 2025	Febbo Phillip G.	Chief Scientific & Med Officer	Sell	$146.81K
Mar 04, 2025	Stapley Marc	Chief Executive Officer	Sell	$925.25K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	10
2024 Q4	-	13
2024 Q3	-	21
2024 Q2	-	5
2024 Q1	-	1

VCYT Ownership FAQ

Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 100.12%, followed by 0.83% insiders and -0.95% retail investors. The average institutional ownership in Veracyte's industry, Biotech Stocks , is 68.48%, which Veracyte exceeds.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Vanguard group (8.21M shares, 10.66%), Blackrock (7.79M shares, 10.42%), and Blackrock funding, inc. /de (7.53M shares, 9.77%). Together, they hold 30.86% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Silverarc capital management is Veracyte’s biggest shareholder by percentage of total assets invested, with 4.36% of its assets in 503.28K Veracyte shares, valued at 19.93M$.

Who is the top mutual fund holder of Veracyte shares?

Vanguard Explorer Inv is the top mutual fund holder of Veracyte shares, with 3.49% of its total shares outstanding invested in 2.7M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools